WASHINGTON, July 13, 2022 /PRNewswire/ — President Joe Biden announced Wednesday he has appointed NASA Administrator Bill Nelson as one of four new members of the Cancer Cabinet, part of the President’s Cancer Moonshot.
“Far too many Americans have been touched by cancer. Ending cancer as we know it has the power to save lives, unite our country, and inspire the world. It is a mission that represents NASA’s ambition to propel humanity forward – for science, for healing, for hope,” said Nelson. “NASA uses the unique microgravity environment on the International Space Station to conduct cutting-edge research with our partners, such as the Mayo Clinic, with the goal of treating serious medical conditions, including blood cancers like leukemia, lymphomas, and multiple myeloma. NASA is no stranger to moon shots, and we’re all in on ending cancer as we know it.”
Five months ago, the President re-ignited the Cancer Moonshot to reduce the death rate from cancer by at least 50 percent over the next 25 years and improve the experience of patients and families living with and surviving cancer. As a part of the Cancer Moonshot, the Cancer Cabinet provides leadership counsel and advice across the federal government on cancer-related programs and priorities.
First Lady Dr. Jill Biden and Dr. Alondra Nelson, deputy assistant to the president and performing the duties of director of the Office of Science and Technology Policy, have announced the following five Cancer Cabinet Priorities, to:
The Cancer Cabinet’s five focus areas of work seek to drive progress through independent agency initiatives and cross-agency collaborations.
The Cancer Cabinet is now expanded to include NASA, the Department of Commerce, the Department of Labor, and the White House Gender Policy Council, adding to the more than 20 departments, agencies, and White House components that make up the cabinet.
For more information about the research and development on the International Space Station, visit:
SOURCE NASA
SOUTH SAN FRANCISCO, Calif., June 08, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO),…
Vancouver, BC, June 07, 2024 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a Burnaby-based clinical-stage biotechnology…
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX,…
Vancouver, British Columbia--(Newsfile Corp. - June 7, 2024) - Numinus Wellness Inc. (TSX: NUMI) (OTCQX:…
WESTBROOK, ME / ACCESSWIRE / June 7, 2024 / What Happened?We discovered unauthorized access on…
Charlotte, North Carolina--(Newsfile Corp. - June 7, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…